Mental Health Bulletin, July 2008



[pic] [pic] [pic]

This bulletin covers sarcomas, soft tissue tumours, bone cancers and GISTs and should be of interest to multidisciplinary teams working in this area.

Sections can include:

• Combined Modality Therapies

• Drug Therapy

• Pathology, Staging, Polymorphisms & Biomarkers

• Prognosis, Survival & Risk Factors

• Radiotherapy & Imaging

• Supportive Care & Symptom Management

• Surgery

Many of the following articles are available online via the NHS Scotland Knowledge Network. Please use the links where provided and your ATHENS password. A complete list of available online journals and registration for ATHENS can be found at knowledge.scot.nhs.uk/

If the article you require is not available via the NHS Scotland Knowledge Network and you would like to request a print copy, please submit your request online at quest.scot.nhs.uk

This bulletin contains a selection of material gathered from a search of the evidence base, and is not intended to be comprehensive. Professional judgment should be exercised when appraising the material. The Library takes no responsibility for the wording, content and accuracy of the information supplied, which has been extracted in good faith from reputable sources. NHSGGC is not responsible for the content of external internet sites.

Compiled by:

Kirsty Coltart

Subject Librarian

Beatson West of Scotland Cancer Centre

0141 301 7285, kirsty.coltart@ggc.scot.nhs.uk

General

Bradford D and Kim A. (2015). Current treatment options for malignant peripheral nerve sheath tumors. Current Treatment Options in Oncology 16,3:328.

Gemici K, Buldu I, Acar T, et al. (2015). Management of patients with retroperitoneal tumors and a review of the literature. World Journal of Surgical Oncology 13,143.

Harlan LC, Eisenstein J, Russell MC, et al. (2015). Gastrointestinal stromal tumors: Treatment patterns of a population-based sample. Journal of surgical oncology 111,6:702-707.

Hwang K, Kim MY and Lee SH. (2015). Recommendations for therapeutic decisions of angiosarcoma of the scalp and face. Journal of Craniofacial Surgery 26,3:e253-6.

Ligier K, Maynou C, Leroy X, et al. (2015). Improvement of the initial management of sarcomas after the dissemination of evidence-based guidelines depends on the primary sarcoma location: a population-based study. BMC Cancer 15,1:218.

Ozaki, T. (2015). Diagnosis and treatment of Ewing sarcoma of the bone: a review article. Journal of Orthopaedic Science 20,2:250-263.

Piccioli A, Maccauro G, Spinelli MS, et al. (2015). Bone metastases of unknown origin: epidemiology and principles of management. Journal of Orthopaedics & Traumatology 16,2:81-86.

Vijay A and Ram L. (2015). Retroperitoneal liposarcoma: a comprehensive review. American Journal of Clinical Oncology 38,2:213-219.

Wilder F, D'Angelo S and Crago AM. (2015). Soft tissue tumors of the trunk: management of local disease in the breast and chest and abdominal walls. Journal of surgical oncology 111,5:546-552.

Combined Modality Therapies

Colombo C, Baratti D, Kusamura S, et al. (2015). The role of hyperthermic intraperitoneal chemotherapy (HIPEC) and isolated perfusion (ILP) interventions in sarcoma. Journal of surgical oncology 111,5:570-579.

Davis LE and Ryan CW. (2015). Preoperative therapy for extremity soft tissue sarcomas. Current Treatment Options in Oncology 16,6:346.

Xu J, Ling TL, Wang M, et al. (2015). Preoperative imatinib treatment in patients with advanced gastrointestinal stromal tumors: patient experiences and systematic review of 563 patients. International surgery 100,5:860-869.

Drug & Targeted Therapy

Bischof DA, Dodson R, Jimenez MC, et al. (2015). Adherence to Guidelines for Adjuvant Imatinib Therapy for GIST: A Multi-institutional Analysis. Journal of Gastrointestinal Surgery 19,6:1022-1028.

Blay JY, Papai Z, Tolcher AW, et al. (2015). Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncology 16,5:531-540.

Burgess M and Tawbi H. (2015). Immunotherapeutic approaches to sarcoma. Current Treatment Options in Oncology 16,6:345.

Casali, P.G. (2015). Adjuvant chemotherapy for soft tissue sarcoma. American Society of Clinical Oncology Educational Book 35,e629-33.

Eroglu Z, Tawbi HA, Hu J, et al. (2015). A randomised phase II trial of selumetinib vs selumetinib plus temsirolimus for soft-tissue sarcomas. British journal of cancer 112,10:1644-1651.

Hensley ML, Miller A, O'Malley DM, et al. (2015). Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: an NRG Oncology/Gynecologic Oncology Group study. Journal of Clinical Oncology 33,10:1180-1185.

Kawai A, Araki N, Sugiura H, et al. (2015). Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study. Lancet Oncology 16,4:406-416.

Liebner, D.A. (2015). The indications and efficacy of conventional chemotherapy in primary and recurrent sarcoma. Journal of surgical oncology 111,5:622-631.

Magnan H, Goodbody CM, Riedel E, et al. (2015). Ifosfamide dose-intensification for patients with metastatic Ewing sarcoma. Pediatric Blood & Cancer 62,4:594-597.

Meyers, P.A. (2015). Systemic therapy for osteosarcoma and ewing sarcoma. American Society of Clinical Oncology Educational Book 35,e644-7.

Nakano K, Motoi N and Takahashi S. (2015). The CYVADIC regimen as a combination chemotherapy treatment option for advanced soft tissue sarcomas originating from the non-extremities. Internal Medicine 54,2:187-193.

Pautier P, Floquet A, Chevreau C, et al. (2015). Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial. Lancet Oncology 16,4:457-464.

Sborov D and Chen JL. (2015). Targeted therapy in sarcomas other than GIST tumors. Journal of surgical oncology 111,5:632-640.

Seddon B, Scurr M, Jones RL, et al. (2015). A phase II trial to assess the activity of gemcitabine and docetaxel as first line chemotherapy treatment in patients with unresectable leiomyosarcoma. Clinical Sarcoma Research 5,13.

Tinoco G, Wilky BA, Paz-Mejia A, et al. (2015). The biology and management of cartilaginous tumors: a role for targeting isocitrate dehydrogenase. American Society of Clinical Oncology Educational Book 35,e648-55.

Yoo KH, Kim HS, Lee SJ, et al. (2015). Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series. BMC Cancer 15,1:154.

Pathology, Staging, Polymorphisms & Biomarkers

Abbas Manji G, Singer S, Koff A, et al. (2015). Application of molecular biology to individualize therapy for patients with liposarcoma. American Society of Clinical Oncology Educational Book 35,213-218.

Alkhasawneh A, Reith JD, Toro TZ, et al. (2015). Interobserver variability of mitotic index and utility of PHH3 for risk stratification in gastrointestinal stromal tumors. American Journal of Clinical Pathology 143,3:385-392.

Brooks JS and Lee S. (2015). Contemporary diagnostics: sarcoma pathology update. Journal of surgical oncology 111,5:513-519.

Klijanienko J, Pierron G, Sastre-Garau X, et al. (2015). Value of combined cytology and molecular information in the diagnosis of soft tissue tumors. Cancer Cytopathology 123,3:141-151.

Massarweh NN, Dickson PV and Anaya DA. (2015). Soft tissue sarcomas: staging principles and prognostic nomograms. Journal of surgical oncology 111,5:532-539.

Shah A, Botchu R, Ashford RU, et al. (2015). Diagnostic triage for sarcoma: an effective model for reducing referrals to the sarcoma multidisciplinary team. British Journal of Radiology 88,1049:20150037.

Smith SM, Coleman J, Bridge JA, et al. (2015). Molecular diagnostics in soft tissue sarcomas and gastrointestinal stromal tumors. Journal of surgical oncology 111,5:520-531.

Prognosis, Survival & Risk Factors

Biswas B, Rastogi S, Khan SA, et al. (2015). Developing a prognostic model for localized Ewing sarcoma family of tumors: A single institutional experience of 224 cases treated with uniform chemotherapy protocol. Journal of surgical oncology 111,6:683-689.

Harrison DJ and Schwartz C. (2015). Survivorship. Journal of surgical oncology 111,5:648-655.

Lee RJ, Arshi A, Schwartz HC, et al. (2015). Characteristics and prognostic factors of osteosarcoma of the jaws: a retrospective cohort study. JAMA Otolaryngology-- Head & Neck Surgery 141,5:470-477.

Pan HY, Morani A, Wang WL, et al. (2015). Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection. International journal of radiation oncology, biology, physics 92,2:349-357.

Thomas DM and Ballinger ML. (2015). Etiologic, environmental and inherited risk factors in sarcomas. Journal of surgical oncology 111,5:490-495.

Tseng WW, Amini B and Madewell JE. (2015). Follow-up of the soft tissue sarcoma patient. Journal of surgical oncology 111,5:641-645.

Urakawa H, Tsukushi S, Arai E, et al. (2015). Association of short duration from initial symptoms to specialist consultation with poor survival in soft-tissue sarcomas. American Journal of Clinical Oncology 38,3:266-271.

Radiotherapy & Imaging

Amini B, Jessop AC, Ganeshan DM, et al. (2015). Contemporary imaging of soft tissue sarcomas. Journal of surgical oncology 111,5:496-503.

Cai PQ, Lv XF, Tian L, et al. (2015). CT Characterization of Duodenal Gastrointestinal Stromal Tumors. AJR.American Journal of Roentgenology 204,5:988-993.

De Amorim Bernstein K and Delaney TF. (2015). Role of radiation therapy for non-extremity soft tissue sarcomas. Journal of surgical oncology 111,5:604-614.

Dickie CI, Haas R and O'Sullivan B. (2015). Adjuvant radiation for soft tissue sarcomas. American Society of Clinical Oncology Educational Book 35,e634-42.

El-Bared N, Wong P and Wang D. (2015). Soft tissue sarcoma and radiation therapy advances, impact on toxicity. Current Treatment Options in Oncology 16,5:335.

Holliday EB, Mitra HS, Somerson JS, et al. (2015). Postoperative proton therapy for chordomas and chondrosarcomas of the spine: adjuvant versus salvage radiation therapy. Spine 40,8:544-549.

Holzapfel K, Regler J, Baum T, et al. (2015). Local Staging of Soft-Tissue Sarcoma: Emphasis on Assessment of Neurovascular Encasement-Value of MR Imaging in 174 Confirmed Cases. Radiology 275,2:501-509.

Miller ED, Xu-Welliver M and Haglund KE. (2015). The role of modern radiation therapy in the management of extremity sarcomas. Journal of surgical oncology 111,5:599-603.

Sahgal A, Chan MW, Atenafu EG, et al. (2015). Image-guided, intensity-modulated radiation therapy (IG-IMRT) for skull base chordoma and chondrosarcoma: preliminary outcomes. Neuro-oncology 17,6:889-894.

Tirumani SH, Wagner AJ, Tirumani H, et al. (2015). Is the nonlipomatous component of dedifferentiated liposarcoma always soft tissue on CT? Analysis of CT densities and correlation with rate of growth in 60 patients. Abdominal Imaging 40,5:1248-1254.

Supportive Care & Symptom Management

Bedi M, King DM, Whitfield R, et al. (2015). The effect of smoking and major vein resection on post-therapy lymphedema in soft tissue sarcomas treated with neoadjuvant radiation and limb-salvage surgery. American Journal of Clinical Oncology 38,2:184-188.

Kimura H, Yamamoto N, Shirai T, et al. (2015). Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-day granisetron for CINV in a randomized, single-blinded crossover study. Cancer Medicine 4,3:333-341.

Tobias K and Gillis T. (2015). Rehabilitation of the sarcoma patient-enhancing the recovery and functioning of patients undergoing management for extremity soft tissue sarcomas. Journal of surgical oncology 111,5:615-621.

Surgery

Aponte-Tinao L, Ayerza MA, Muscolo DL, et al. (2015). Survival, recurrence, and function after epiphyseal preservation and allograft reconstruction in osteosarcoma of the knee. Clinical Orthopaedics & Related Research 473,5:1789-1796.

Bate BG, Khan NR, Kimball BY, et al. (2015). Stereotactic radiosurgery for spinal metastases with or without separation surgery. Journal of Neurosurgery Spine 22,4:409-415.

Bogani G, Cliby WA and Aletti GD. (2015). Impact of morcellation on survival outcomes of patients with unexpected uterine leiomyosarcoma: a systematic review and meta-analysis. Gynecologic oncology 137,1:167-172.

Cai JQ, Chen K, Mou YP, et al. (2015). Laparoscopic versus open wedge resection for gastrointestinal stromal tumors of the stomach: a single-center 8-year retrospective cohort study of 156 patients with long-term follow-up. BMC Surgery 15,1:58.

Chao AH, Mayerson JL, Chandawarkar R, et al. (2015). Surgical management of soft tissue sarcomas: extremity sarcomas. Journal of surgical oncology 111,5:540-545.

Fairweather M and Raut CP. (2015). Surgical management of GIST and intra-abdominal visceral leiomyosarcomas. Journal of surgical oncology 111,5:562-569.

Fischer S, Soimaru S, Hirsch T, et al. (2015). Local tendon transfer for knee extensor mechanism reconstruction after soft tissue sarcoma resection. Journal of Plastic, Reconstructive & Aesthetic Surgery: JPRAS 68,5:729-735.

Hsiao CY, Yang CY, Lai IR, et al. (2015). Laparoscopic resection for large gastric gastrointestinal stromal tumor (GIST): intermediate follow-up results. Surgical endoscopy 29,4:868-873.

Khansa I and Janis JE. (2015). Modern reconstructive techniques for abdominal wall defects after oncologic resection. Journal of surgical oncology 111,5:587-598.

Lin YH, Lin CC, Concejero AM, et al. (2015). Surgical experience of adult primary hepatic sarcomas. World Journal of Surgical Oncology 13,87.

Mattei TA, Teles AR and Mendel E. (2015). Modern surgical techniques for management of soft tissue sarcomas involving the spine: outcomes and complications. Journal of surgical oncology 111,5:580-586.

Moussazadeh N, Kulwin C, Anand VK, et al. (2015). Endoscopic endonasal resection of skull base chondrosarcomas: technique and early results. Journal of neurosurgery 122,4:735-742.

Pretell-Mazzini J, Barton MD Jr, Conway SA, et al. (2015). Unplanned excision of soft-tissue sarcomas: current concepts for management and prognosis. Journal of Bone & Joint Surgery - American Volume 97,7:597-603.

Racz JM, Sunil S, Abramowitz D, et al. (2015). Multivisceral resections for gastrointestinal stromal tumors: are the risks justifiable? Surgical oncology 24,1:54-59..

Tuttle R and Kane JM 3rd. (2015). Biopsy techniques for soft tissue and bowel sarcomas. Journal of surgical oncology 111,5:504-512.

Zhang FB, Shi HC, Shu YS, et al. (2015). Diagnosis and surgical treatment of esophageal gastrointestinal stromal tumors. World Journal of Gastroenterology 21,18:5630-5634.

Please note that the journal articles you are accessing are subject to the terms and conditions imposed by the publisher, so there will be a limit on the number of articles an individual may download or print from a single issue of a journal. You can consult your local NHSGGC library with any queries.

If you have any questions regarding this or any other library services please contact Library staff – contact details are at the beginning of the bulletin.

Sources used for this bulletin:

OVID MEDLINE, SIGN, NICE and Healthcare Improvement Scotland

-----------------------

Sarcoma & Bone Cancer

May 2015

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download